Prime-Express Scripts Merger Looks Unlikely Despite New Deal

Prime Therapeutics, the PBM jointly owned by 18 Blue Cross Blue Shield plans, recently entered an agreement with Cigna Corp.-owned PBM Express Scripts to offer Blues plans the option of using Express Scripts’ mail order and specialty pharmacy services. Though experts say a merger of the two PBMs is unlikely, the deal deepens the trend of integration and consolidation across the PBM space and between the two firms, which have shared some joint operations since the end of 2019.

Kyle Skiermont, Pharm.D., Prime’s senior vice president for specialty pharmacy and home delivery, tells AIS Health that the deal’s purpose is to offer Blues plans a choice between Prime’s specialty and mail order pharmacy operations and Express Scripts’ specialty branch, Accredo. Prime has an existing mail order and specialty joint venture with Walgreens Boots Alliance Inc., called AllianceRx Walgreens Prime.

© 2023 MMIT
Peter Johnson

Peter Johnson

Peter has been a reporter for nearly a decade. Before joining AIS Health, Peter covered a wide variety of topics in his hometown of Seattle, where he continues to live. Peter’s work has appeared in publications including The Atlantic and The Stranger. Peter attended Colby College.

Related Posts

businessman-viewing-news-update-journalism-headline-on-a-laptop
November 22

News Briefs: CDC Makes More RSV Immunizations Available to Infants

READ MORE
dna-strand
November 22

Papers Delve Into Payment Options for Gene Therapies

READ MORE
pills
November 22

A Closer Look at the Medicare Part D Landscape

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today